 Jason Christie
Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Purkinje Cells | 9 | 2023 | 71 | 4.040 |
Why?
| | Cerebellum | 11 | 2024 | 218 | 3.660 |
Why?
| | Interneurons | 11 | 2023 | 118 | 2.700 |
Why?
| | Dendrites | 6 | 2021 | 98 | 2.440 |
Why?
| | Cerebellar Cortex | 4 | 2019 | 21 | 2.050 |
Why?
| | Axons | 7 | 2019 | 191 | 1.930 |
Why?
| | Calcium Signaling | 7 | 2021 | 250 | 1.880 |
Why?
| | Action Potentials | 9 | 2021 | 485 | 1.840 |
Why?
| | Presynaptic Terminals | 4 | 2017 | 83 | 1.700 |
Why?
| | Synapses | 5 | 2019 | 396 | 1.600 |
Why?
| | Movement | 4 | 2022 | 269 | 1.320 |
Why?
| | Potassium Channels | 4 | 2017 | 149 | 1.220 |
Why?
| | Neural Inhibition | 3 | 2018 | 158 | 1.220 |
Why?
| | Learning | 3 | 2022 | 401 | 1.160 |
Why?
| | Neuronal Plasticity | 3 | 2021 | 279 | 0.860 |
Why?
| | Patch-Clamp Techniques | 10 | 2018 | 279 | 0.840 |
Why?
| | Synaptic Transmission | 7 | 2022 | 272 | 0.780 |
Why?
| | Olfactory Bulb | 4 | 2006 | 136 | 0.770 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 5 | 2014 | 211 | 0.720 |
Why?
| | Shaw Potassium Channels | 2 | 2017 | 4 | 0.660 |
Why?
| | Olivary Nucleus | 1 | 2019 | 16 | 0.630 |
Why?
| | Motor Activity | 2 | 2021 | 675 | 0.600 |
Why?
| | Nerve Net | 2 | 2018 | 260 | 0.570 |
Why?
| | Mice | 17 | 2024 | 16915 | 0.570 |
Why?
| | Animals | 26 | 2024 | 35309 | 0.560 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2017 | 68 | 0.540 |
Why?
| | Microscopy, Fluorescence | 2 | 2015 | 398 | 0.540 |
Why?
| | Functional Neuroimaging | 1 | 2015 | 73 | 0.480 |
Why?
| | Connexins | 2 | 2006 | 51 | 0.480 |
Why?
| | Receptors, Presynaptic | 1 | 2014 | 8 | 0.450 |
Why?
| | Psychomotor Performance | 1 | 2017 | 313 | 0.440 |
Why?
| | Mice, Transgenic | 4 | 2021 | 2117 | 0.410 |
Why?
| | Calcium | 4 | 2017 | 1212 | 0.410 |
Why?
| | Excitatory Amino Acid Antagonists | 5 | 2009 | 100 | 0.400 |
Why?
| | Reflex, Vestibulo-Ocular | 2 | 2022 | 10 | 0.390 |
Why?
| | Ion Channel Gating | 2 | 2009 | 94 | 0.390 |
Why?
| | Behavior, Animal | 1 | 2015 | 506 | 0.380 |
Why?
| | Brain Mapping | 1 | 2015 | 574 | 0.380 |
Why?
| | Periodicity | 2 | 2022 | 57 | 0.330 |
Why?
| | Pyramidal Cells | 1 | 2009 | 69 | 0.310 |
Why?
| | Ion Channels | 1 | 2009 | 133 | 0.310 |
Why?
| | Optogenetics | 2 | 2021 | 112 | 0.300 |
Why?
| | Calcium Channels | 1 | 2008 | 164 | 0.280 |
Why?
| | Touch Perception | 2 | 2018 | 16 | 0.280 |
Why?
| | Touch | 2 | 2018 | 37 | 0.270 |
Why?
| | Haploinsufficiency | 2 | 2024 | 48 | 0.270 |
Why?
| | In Vitro Techniques | 5 | 2009 | 1085 | 0.260 |
Why?
| | Receptors, AMPA | 4 | 2014 | 141 | 0.250 |
Why?
| | Evoked Potentials, Somatosensory | 1 | 2006 | 33 | 0.250 |
Why?
| | Rats, Sprague-Dawley | 6 | 2010 | 2396 | 0.250 |
Why?
| | Olfactory Pathways | 1 | 2006 | 60 | 0.250 |
Why?
| | Neurons, Afferent | 1 | 2006 | 99 | 0.240 |
Why?
| | Rats | 7 | 2010 | 5482 | 0.240 |
Why?
| | Membrane Potentials | 4 | 2009 | 293 | 0.240 |
Why?
| | Signal Transduction | 2 | 2017 | 4926 | 0.230 |
Why?
| | DiGeorge Syndrome | 1 | 2024 | 29 | 0.230 |
Why?
| | T-Box Domain Proteins | 1 | 2024 | 96 | 0.220 |
Why?
| | Cerebellar Vermis | 1 | 2023 | 4 | 0.220 |
Why?
| | Excitatory Postsynaptic Potentials | 2 | 2018 | 119 | 0.220 |
Why?
| | Mice, Inbred C57BL | 4 | 2018 | 5439 | 0.220 |
Why?
| | Microscopy, Confocal | 2 | 2019 | 305 | 0.210 |
Why?
| | Glutamic Acid | 4 | 2008 | 235 | 0.210 |
Why?
| | Neurons | 3 | 2018 | 1494 | 0.190 |
Why?
| | Receptors, GABA-A | 3 | 2022 | 126 | 0.190 |
Why?
| | Gold Colloid | 1 | 2021 | 1 | 0.180 |
Why?
| | Channelrhodopsins | 1 | 2021 | 16 | 0.180 |
Why?
| | Receptor, Cannabinoid, CB1 | 1 | 2021 | 40 | 0.180 |
Why?
| | Muscular Dystrophy, Duchenne | 1 | 2022 | 89 | 0.180 |
Why?
| | Electric Stimulation | 3 | 2009 | 269 | 0.180 |
Why?
| | Endocannabinoids | 1 | 2021 | 53 | 0.170 |
Why?
| | Microscopy, Electron | 1 | 2021 | 426 | 0.170 |
Why?
| | Hippocampus | 1 | 2006 | 871 | 0.170 |
Why?
| | Metal Nanoparticles | 1 | 2021 | 81 | 0.170 |
Why?
| | Wakefulness | 1 | 2021 | 120 | 0.170 |
Why?
| | Piperidines | 1 | 2021 | 198 | 0.160 |
Why?
| | Excitatory Amino Acid Agonists | 2 | 2009 | 40 | 0.160 |
Why?
| | ras GTPase-Activating Proteins | 1 | 2018 | 15 | 0.160 |
Why?
| | Physical Stimulation | 1 | 2019 | 75 | 0.150 |
Why?
| | Water | 1 | 2022 | 441 | 0.150 |
Why?
| | Sensation Disorders | 1 | 2018 | 32 | 0.150 |
Why?
| | Somatosensory Cortex | 1 | 2018 | 36 | 0.150 |
Why?
| | Evoked Potentials, Motor | 1 | 2018 | 40 | 0.150 |
Why?
| | Photic Stimulation | 1 | 2019 | 240 | 0.140 |
Why?
| | Male | 9 | 2024 | 63517 | 0.140 |
Why?
| | Pyrazoles | 1 | 2021 | 404 | 0.140 |
Why?
| | Acoustic Stimulation | 1 | 2019 | 328 | 0.140 |
Why?
| | Neural Pathways | 1 | 2019 | 302 | 0.140 |
Why?
| | Tongue | 1 | 2017 | 76 | 0.130 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2021 | 742 | 0.130 |
Why?
| | Quinoxalines | 2 | 2009 | 64 | 0.130 |
Why?
| | Drinking Behavior | 1 | 2015 | 10 | 0.130 |
Why?
| | Vibrissae | 1 | 2015 | 10 | 0.130 |
Why?
| | Female | 7 | 2024 | 68556 | 0.120 |
Why?
| | Protein Kinase C | 1 | 2017 | 260 | 0.120 |
Why?
| | Shaker Superfamily of Potassium Channels | 1 | 2014 | 3 | 0.110 |
Why?
| | Electrophysiological Phenomena | 1 | 2014 | 54 | 0.110 |
Why?
| | Fluorescent Dyes | 1 | 2014 | 312 | 0.100 |
Why?
| | 2-Amino-5-phosphonovalerate | 2 | 2003 | 12 | 0.100 |
Why?
| | Brain | 2 | 2021 | 2669 | 0.090 |
Why?
| | Egtazic Acid | 1 | 2010 | 41 | 0.090 |
Why?
| | Iontophoresis | 1 | 2009 | 13 | 0.080 |
Why?
| | Immunohistochemistry | 1 | 2014 | 1691 | 0.080 |
Why?
| | N-Methylaspartate | 1 | 2009 | 39 | 0.080 |
Why?
| | Glutamates | 1 | 2009 | 57 | 0.080 |
Why?
| | Organ Culture Techniques | 1 | 2008 | 153 | 0.070 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2009 | 168 | 0.070 |
Why?
| | Long-Term Synaptic Depression | 1 | 2008 | 56 | 0.070 |
Why?
| | Animals, Newborn | 1 | 2009 | 834 | 0.070 |
Why?
| | Piperazines | 1 | 2009 | 341 | 0.070 |
Why?
| | Indoles | 1 | 2009 | 384 | 0.070 |
Why?
| | Cerebral Cortex | 1 | 2009 | 436 | 0.060 |
Why?
| | Synaptic Vesicles | 1 | 2006 | 42 | 0.060 |
Why?
| | Gap Junctions | 1 | 2005 | 61 | 0.060 |
Why?
| | Temporal Bone | 1 | 2024 | 49 | 0.060 |
Why?
| | Osteoblasts | 1 | 2024 | 116 | 0.050 |
Why?
| | Long-Term Potentiation | 1 | 2006 | 196 | 0.050 |
Why?
| | Skull | 1 | 2024 | 129 | 0.050 |
Why?
| | 4-Aminopyridine | 1 | 2003 | 24 | 0.050 |
Why?
| | Tetrodotoxin | 1 | 2003 | 39 | 0.050 |
Why?
| | Potassium Channel Blockers | 1 | 2003 | 36 | 0.050 |
Why?
| | Disease Models, Animal | 2 | 2024 | 4057 | 0.050 |
Why?
| | Pyridazines | 1 | 2003 | 54 | 0.050 |
Why?
| | Chondrocytes | 1 | 2024 | 203 | 0.050 |
Why?
| | Memory Disorders | 1 | 2023 | 168 | 0.050 |
Why?
| | Mice, Inbred mdx | 1 | 2022 | 13 | 0.050 |
Why?
| | GABA-A Receptor Antagonists | 1 | 2001 | 17 | 0.040 |
Why?
| | GABA Antagonists | 1 | 2001 | 33 | 0.040 |
Why?
| | Mice, Knockout | 1 | 2005 | 2871 | 0.040 |
Why?
| | Cells, Cultured | 1 | 2006 | 4077 | 0.040 |
Why?
| | Cell Differentiation | 1 | 2024 | 1887 | 0.030 |
Why?
| | Binding Sites | 1 | 2000 | 1250 | 0.030 |
Why?
| | Cognition | 1 | 2018 | 1122 | 0.020 |
Why?
| | Registries | 1 | 2018 | 1895 | 0.020 |
Why?
| | Humans | 3 | 2024 | 129271 | 0.010 |
Why?
|
|
Christie's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|